Literature DB >> 11148943

A continuous-improvement approach for reducing the number of chemotherapy-related medication errors.

B R Goldspiel1, R DeChristoforo, C E Daniels.   

Abstract

A comprehensive, interdisciplinary approach for reducing the number of chemotherapy-related medication errors at the National Institutes of Health Clinical Center, where approximately 8500 doses of chemotherapy agents are dispensed annually, is described. Heightened awareness of the seriousness of chemotherapy-related medication errors prompted formation of an interdisciplinary task force in June 1995 to analyze and improve the hospital's system for ordering, checking, processing, and administering cancer chemotherapy agents. Problems were analyzed and rectified in accordance with the hospital's plan-do-check-act performance-improvement model. Performance monitors for the improvements included a system to record and categorize all chemotherapy-related prescribing errors and a hospital-wide occurrence-reporting system. The task force identified seven major categories in which improvements were needed: protocol development, computer-system enhancements, dose verification, information access, education for health care practitioners, error follow-up, and infusion pumps. Despite the Clinical Center's good safety-net system, 23 modifications were made to the existing system through December 1999. These changes resulted in an overall 23% decrease in prescribing errors and a 53% decrease in serious prescribing errors. The task force membership was recently broadened to include representatives of additional departments where chemotherapy agents are used, and this group recommended more than 20 additional system changes. The changes are being implemented, and their effect on reducing the number of chemotherapy-related errors will be measured. The continuous-improvement process used prospectively by the task force helps ensure that safe chemotherapy practices are instituted uniformly throughout the hospital.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11148943     DOI: 10.1093/ajhp/57.suppl_4.S4

Source DB:  PubMed          Journal:  Am J Health Syst Pharm        ISSN: 1079-2082            Impact factor:   2.637


  11 in total

1.  Quality performance improvement with the implementation of standard chemotherapy order forms.

Authors:  Lena Dumasia; Ellen Harris; Anibal Drelichman
Journal:  J Oncol Pract       Date:  2006-05       Impact factor: 3.840

2.  Program to support safe administration of oral chemotherapy.

Authors:  Ann M Birner; Marilyn K Bedell; Jean T Avery; Marc S Ernstoff
Journal:  J Oncol Pract       Date:  2006-01       Impact factor: 3.840

3.  Harmonization of Busulfan Plasma Exposure Unit (BPEU): A Community-Initiated Consensus Statement.

Authors:  Jeannine S McCune; Christine M Quinones; James Ritchie; Paul A Carpenter; Erik van Maarseveen; Rosa F Yeh; Claudio Anasetti; Jaap J Boelens; Nelson Hamerschlak; Moustapha Hassan; Hyoung Jin Kang; Yoshinobu Kanda; Angelo Paci; Miguel-Angel Perales; Peter J Shaw; Victoria L Seewaldt; Bipin N Savani; Angela Hsieh; Betsy Poon; Mohamad Mohty; Michael A Pulsipher; Marcelo Pasquini; L Lee Dupuis
Journal:  Biol Blood Marrow Transplant       Date:  2019-05-25       Impact factor: 5.742

4.  Prescription errors with cytotoxic drugs and the inadequacy of existing classifications.

Authors:  Cyril Slama; Joëlle Jerome; Christian Jacquot; Brigitte Bonan
Journal:  Pharm World Sci       Date:  2005-08

5.  Advancing the Future of Patient Safety in Oncology: Implications of Patient Safety Education on Cancer Care Delivery.

Authors:  Ted A James; Michael Goedde; Tania Bertsch; Dennis Beatty
Journal:  J Cancer Educ       Date:  2016-09       Impact factor: 2.037

6.  Clinical and economic impact of pharmacists' intervention in a large volume chemotherapy preparation unit.

Authors:  Ji-Min Han; Young-Mi Ah; Sung Yun Suh; Sun-Hoi Jung; Hyeon Joo Hahn; Seock-Ah Im; Ju-Yeun Lee
Journal:  Int J Clin Pharm       Date:  2016-06-30

7.  Evaluation of clinical interventions made by pharmacists in chemotherapy preparation.

Authors:  Lea Knez; Raisa Laaksonen; Catherine Duggan
Journal:  Radiol Oncol       Date:  2010-09-22       Impact factor: 2.991

8.  Guideline adherence to chemotherapy administration safety standards: a survey on nurses in a single institute.

Authors:  Kidong Kim; Hee Sook Lee; Younha Kim; Beob-Jong Kim; Moon-Hong Kim; Seok-Cheol Choi; Sang-Young Ryu
Journal:  J Gynecol Oncol       Date:  2011-03-31       Impact factor: 4.401

Review 9.  Minimising treatment-associated risks in systemic cancer therapy.

Authors:  Ulrich Jaehde; Andrea Liekweg; Sven Simons; Martina Westfeld
Journal:  Pharm World Sci       Date:  2007-09-29

10.  'Saying it without words': a qualitative study of oncology staff's experiences with speaking up about safety concerns.

Authors:  D L B Schwappach; K Gehring
Journal:  BMJ Open       Date:  2014-05-16       Impact factor: 2.692

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.